Ubiquitin Aldehyde, human recombinant protein
Ubiquitin Aldehyde
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Calculated MW | 8.5 kDa |
---|
Other Names | Ubiquitin Aldehyde |
---|---|
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; |
Assay2&Purity2 | HPLC; ≥95% |
Recombinant | Yes |
Format | Liquid |
Storage | -80°C. Do not lyophilize. Do not neutralize until immediately prior to use. Avoid presence of amino containing compounds.; An aqueous solution containing 0.15 M HCl |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The C-terminal glycine carboxyl of Ubiquitin is synthetically modified to an aldehyde. Ubiquitin Aldehyde (Ub-H) is useful in the stabilization of ubiquitin-protein conjugates in vitro, enhancing their accumulation in cell lysates and tissue extracts. Inhibition of deubiquitinylating enzyme activity by Ub-H can be used to identify and confirm such activity and to determine the inhibition kinetics for a particular enzyme. Recommended concentration for maximal inhibition is 2-5 µM. Co-crystallization of ubiquitin aldehyde with specific deubiquitinylating enzymes (the inhibitor mimics the natural ubiquitin substrate) has also been used to probe enzyme:substrate interactions.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.